Natalizumab treatment reduces fatigue in multiple sclerosis. Results from the TYNERGY trial; a study in the real life setting.

by Anders Svenningsson, Eva Falk, Elisabeth G Celius, Siegrid Fuchs, Karen Schreiber, Sara Berkö, Jennifer Sun, Iris-Katharina Penner, Tynergy Trial Investigators
Published 2013-01-01

Neurodegenerative Interplay of Cardiovascular Autonomic Dysregulation and the Retina in Early Multiple Sclerosis

by Sigrid A. de Rodez Benavent, Sigrid A. de Rodez Benavent, Gro O. Nygaard, Kristian B. Nilsen, Kristian B. Nilsen, Lars Etholm, Piotr Sowa, Marte Wendel-Haga, Marte Wendel-Haga, Hanne F. Harbo, Hanne F. Harbo, Liv Drolsum, Liv Drolsum, Bruno Laeng, Emilia Kerty, Emilia Kerty, Elisabeth G. Celius, Elisabeth G. Celius
Published 2019-05-01

Genetic association of multiple sclerosis with the marker rs391745 near the endogenous retroviral locus HERV-Fc1: analysis of disease subtypes.

by Bettina Hansen, Annette B Oturai, Hanne F Harbo, Elisabeth G Celius, Kari K Nissen, Magdalena J Laska, Helle B Søndergaard, Thor Petersen, Bjørn A Nexø
Published 2011-01-01

Multiple Sclerosis Risk Allele in CLEC16A Acts as an Expression Quantitative Trait Locus for CLEC16A and SOCS1 in CD4+ T Cells.

by Ingvild S Leikfoss, Pankaj K Keshari, Marte W Gustavsen, Anja Bjølgerud, Ina S Brorson, Elisabeth G Celius, Anne Spurkland, Steffan D Bos, Hanne F Harbo, Tone Berge
Published 2015-01-01

Importance of human leukocyte antigen (HLA) class I and II alleles on the risk of multiple sclerosis.

by Jenny Link, Ingrid Kockum, Aslaug R Lorentzen, Benedicte A Lie, Elisabeth G Celius, Helga Westerlind, Marie Schaffer, Lars Alfredsson, Tomas Olsson, Boel Brynedal, Hanne F Harbo, Jan Hillert
Published 2012-01-01

A Longitudinal Study of Disability, Cognition and Gray Matter Atrophy in Early Multiple Sclerosis Patients According to Evidence of Disease Activity.

by Gro O Nygaard, Elisabeth G Celius, Sigrid A de Rodez Benavent, Piotr Sowa, Marte W Gustavsen, Anders M Fjell, Nils I Landrø, Kristine B Walhovd, Hanne F Harbo
Published 2015-01-01

Quality of Life Improves with Alemtuzumab Over 6 Years in Relapsing-Remitting Multiple Sclerosis Patients with or without Autoimmune Thyroid Adverse Events: Post Hoc Analysis of th...

by Antonio Bertolotto, Rafael Arroyo, Elisabeth G. Celius, Giancarlo Comi, Eva Kubala Havrdova, William David Honeycutt, Samuel F. Hunter, Guillermo Izquierdo, Barbara Kornek, Tamara Miller, Dimos D. Mitsikostas, Barry A. Singer, Tjalf Ziemssen, Luke Chung, Nadia Daizadeh, Salman Afsar, Lobat Hashemi, Peter Senior
Published 2020-05-01

Best Practices for Long-Term Monitoring and Follow-Up of Alemtuzumab-Treated MS Patients in Real-World Clinical Settings

by Krista Barclay, Robert Carruthers, Anthony Traboulsee, Ann D. Bass, Christopher LaGanke, Antonio Bertolotto, Aaron Boster, Elisabeth G. Celius, Jérôme de Seze, Dionisio Dela Cruz, Mario Habek, Jong-Mi Lee, Volker Limmroth, Sven G. Meuth, Celia Oreja-Guevara, Patricia Pagnotta, Cindy Vos, Tjalf Ziemssen, Darren P. Baker, Bart Van Wijmeersch
Published 2019-03-01

Oligoclonal band status in Scandinavian multiple sclerosis patients is associated with specific genetic risk alleles.

by Inger-Lise Mero, Marte W Gustavsen, Hanne S Sæther, Siri T Flåm, Pål Berg-Hansen, Helle B Søndergaard, Poul Erik H Jensen, Tone Berge, Anja Bjølgerud, Aslaug Muggerud, Jan H Aarseth, International Multiple Sclerosis Genetics Consortium, Kjell-Morten Myhr, Elisabeth G Celius, Finn Sellebjerg, Jan Hillert, Lars Alfredsson, Tomas Olsson, Annette Bang Oturai, Ingrid Kockum, Benedicte A Lie, Bettina Kulle Andreassen, Hanne F Harbo
Published 2013-01-01

DNA methylation as a mediator of HLA-DRB1*15:01 and a protective variant in multiple sclerosis

by Lara Kular, Yun Liu, Sabrina Ruhrmann, Galina Zheleznyakova, Francesco Marabita, David Gomez-Cabrero, Tojo James, Ewoud Ewing, Magdalena Lindén, Bartosz Górnikiewicz, Shahin Aeinehband, Pernilla Stridh, Jenny Link, Till F. M. Andlauer, Christiane Gasperi, Heinz Wiendl, Frauke Zipp, Ralf Gold, Björn Tackenberg, Frank Weber, Bernhard Hemmer, Konstantin Strauch, Stefanie Heilmann-Heimbach, Rajesh Rawal, Ulf Schminke, Carsten O. Schmidt, Tim Kacprowski, Andre Franke, Matthias Laudes, Alexander T. Dilthey, Elisabeth G. Celius, Helle B. Søndergaard, Jesper Tegnér, Hanne F. Harbo, Annette B. Oturai, Sigurgeir Olafsson, Hannes P. Eggertsson, Bjarni V. Halldorsson, Haukur Hjaltason, Elias Olafsson, Ingileif Jonsdottir, Kari Stefansson, Tomas Olsson, Fredrik Piehl, Tomas J. Ekström, Ingrid Kockum, Andrew P. Feinberg, Maja Jagodic
Published 2018-06-01

Fourteen sequence variants that associate with multiple sclerosis discovered by meta-analysis informed by genetic correlations

by Sigurgeir Olafsson, Pernilla Stridh, Steffan Daniël Bos, Andres Ingason, Jack Euesden, Patrick Sulem, Gudmar Thorleifsson, Omar Gustafsson, Ari Johannesson, Arni J. Geirsson, Arni V. Thorsson, Bardur Sigurgeirsson, Bjorn Runar Ludviksson, Elias Olafsson, Helga Kristjansdottir, Jon G. Jonasson, Jon Hjaltalin Olafsson, Kjartan B. Orvar, Rafn Benediktsson, Ragnar Bjarnason, Sjofn Kristjansdottir, Thorarinn Gislason, Trausti Valdimarsson, Evgenia Mikaelsdottir, Snaevar Sigurdsson, Stefan Jonsson, Thorunn Rafnar, Dag Aarsland, Srdjan Djurovic, Tormod Fladby, Gun Peggy Knudsen, Elisabeth G. Celius, Kjell-Morten Myhr, Gerdur Grondal, Kristjan Steinsson, Helgi Valdimarsson, Sigurdur Bjornsson, Unnur S. Bjornsdottir, Einar S Bjornsson, Bjorn Nilsson, Ole A. Andreassen, Lars Alfredsson, Jan Hillert, Ingrid Skelton Kockum, Gisli Masson, Unnur Thorsteinsdottir, Daniel F. Gudbjartsson, Hreinn Stefansson, Haukur Hjaltason, Hanne F. Harbo, Tomas Olsson, Ingileif Jonsdottir, Kari Stefansson
Published 2017-08-01